Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer
阿昔替尼和克唑替尼联合治疗可抑制去势抵抗性前列腺癌小鼠模型中的骨质流失
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/1471-2407-14-742
Jeetendra Eswaraka, Anand Giddabasappa, Guangzhou Han, Kush Lalwani, Koleen Eisele, Zheng Feng, Timothy Affolter, James Christensen, Gang Li
